Global Transplant Diagnostics Market Growth (Status and Outlook) 2023-2029

Global Transplant Diagnostics Market Growth (Status and Outlook) 2023-2029

The demand of transplant diagnostics is increasing repuily.

LPI (LP Information)' newest research report, the “Transplant Diagnostics Industry Forecast” looks at past sales and reviews total world Transplant Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Transplant Diagnostics sales for 2023 through 2029. With Transplant Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transplant Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Transplant Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transplant Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transplant Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transplant Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transplant Diagnostics.

The global Transplant Diagnostics market size is projected to grow from US$ 3764.9 million in 2022 to US$ 5525.2 million in 2029; it is expected to grow at a CAGR of 5.6% from 2023 to 2029.

United States market for Transplant Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Transplant Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Transplant Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Transplant Diagnostics players cover BD, Biofortuna, Biomérieux SA, Bio-Rad Laboratories, Caredx, F. Hoffman-La Roche, Gendx, Hologic and Illumina, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Transplant Diagnostics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Solid Organ Transplantation
Stem Cell Transplantation
Soft Tissue Transplantation
Bone Marrow Transplantation

Segmentation by application
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
Biofortuna
Biomérieux SA
Bio-Rad Laboratories
Caredx
F. Hoffman-La Roche
Gendx
Hologic
Illumina
Immucor
Luminex
Merck KGaA
Omixon
Qiagen
Thermo Fisher Scientific

Please note: The report will take approximately 2 business days to prepare and deliver.